Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 2, 2011, Pages

  Banerjee, Sanjita ^a   Jin, Ge ^a   Bradley, S Gaylen ^a   Matters, Gail L ^a   Gailey, Ryan D ^a   Crisman, Jacqueline M ^a   Bond, Judith S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Intestine; Knockout mice; Metalloproteinase

Indexed keywords

ALBUMIN; CREATININE; DEXTRAN SULFATE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEPRIN; MEPRIN B; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE; RANTES; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENOTYPE; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WEIGHT REDUCTION; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; COLITIS; DEXTRAN SULFATE; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-6; INTESTINES; MALE; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; PERMEABILITY; PEROXIDASE; SEVERITY OF ILLNESS INDEX;

EID: 79251569567     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00504.2009     Document Type: Article

References (38)

1. Ambort D, Stalder D, Lottaz D, Huguenin M, Oneda B, Heller M, Sterchi EE. A novel 2D-based approach to the discovery of candidate substrates for the metalloendopeptidase meprin. FEBS J 275: 4490-4509, 2008.
2. Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28: 187-196, 2005. (Pubitemid 41208908)
3. Banerjee S, Bond JS. Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation. J Biol Chem 283: 31371-31377, 2008.
4. Banerjee S, Oneda B, Yap LM, Jewell DP, Matters GL, Fitzpatrick LR, Seibold F, Sterchi EE, Ahmad T, Lottaz D, Bond JS. MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunol 2: 220-231, 2009.
5. Becker-Pauly C, Howel M, Walker T, Vlad A, Aufenvenne K, Oji V, Lottaz D, Sterchi EE, Debela M, Magdolen V, Traupe H, Stocker W. The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation. J Invest Dermatol 127: 1115-1125, 2007.
6. Bergin DA, Greene CM, Sterchi EE, Kenna C, Geraghty P, Taggart CC, O'Neill SJ, McElvaney NG. Activation of EGFR by a novel metalloprotease pathway. J Biol Chem 283: 31736-31744, 2008.
7. Bertenshaw GP, Turk BE, Hubbard SJ, Matters GL, Bylander JE, Crisman JM, Cantley LC, Bond JS. Marked differences between metalloproteases meprin A and B in substrate and peptide bond specificity. J Biol Chem 276: 13248-13255, 2001. (Pubitemid 37385255)
8. Boismenu R, Chen Y. Insights from mouse models of colitis. J Leukoc Biol 67: 267-278, 2000.
9. Bond JS, Gailey R, Bradley G. Meprin metalloproteases in intestinal disease. In: The Brush Border Membrane; From Molecular Cell Biology to Clinical Pathology (1st ed.), edited by Naim HY and Zimmer KP. Heilbronn, Germany: SPS Publications, 2006, p. 122-135.
10. Bond JS, Matters GL, Banerjee S, Dusheck RE. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett 579: 3317-3322, 2005. (Pubitemid 40804680)
11. Bond JS, Rojas K, Overhauser J, Zoghbi HY, Jiang W. The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively. Genomics 25: 300-303, 1995.
12. Bylander J, Li Q, Ramesh G, Zhang B, Reeves WB, Bond JS. Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 294: F480-F490, 2008.
13. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249, 1993.
14. Crisman JM, Zhang B, Norman LP, Bond JS. Deletion of the mouse meprin beta metalloprotease gene diminishes the ability of leukocytes to disseminate through extracellular matrix. J Immunol 172: 4510-4519, 2004.
15. Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, Grail D, Ernst M, Jones SA, Topley N, Jenkins BJ. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 181: 2189-2195, 2008.
16. Garg P, Rojas M, Ravi A, Bockbrader K, Epstein S, Vijay-Kumar M, Gewirtz AT, Merlin D, Sitaraman SV. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis. J Immunol 177: 4103-4112, 2006.
17. Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol Gastrointest Liver Physiol 296: G175-G184, 2009.
18. Gorbea CM, Marchand P, Jiang W, Copeland NG, Gilbert DJ, Jenkins NA, Bond JS. Cloning, expression, and chromosomal localization of the mouse meprin beta subunit. J Biol Chem 268: 21035-21043, 1993. (Pubitemid 23292287)
19. Hahn D, Illisson R, Metspalu A, Sterchi EE. Human N-benzoyl-Ltyrosyl- p-aminobenzoic acid hydrolase (human meprin): genomic structure of the alpha and beta subunits. Biochem J 346: 83-91, 2000.
20. Hengst JA, Bond JS. Transport of meprin subunits through the secretory pathway: role of the transmembrane and cytoplasmic domains and oligomerization. J Biol Chem 279: 34856-34864, 2004.
21. Herzog C, Haun RS, Kaushal V, Mayeux PR, Shah SV, Kaushal GP. Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta. Biochem Biophys Res Commun 379: 904-908, 2009.
22. Herzog C, Kaushal GP, Haun RS. Generation of biologically active interleukin-1beta by meprin B. Cytokine 31: 394-403, 2005.
23. Huguenin M, Muller EJ, Trachsel-Rosmann S, Oneda B, Ambort D, Sterchi EE, Lottaz D. The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion. PLoS One 3: e2153, 2008.
24. Ishmael FT, Shier VK, Ishmael SS, Bond JS. Intersubunit and domain interactions of the meprin B metalloproteinase. Disulfide bonds and protein-protein interactions in the MAM and TRAF domains. J Biol Chem 280: 13895-13901, 2005.
25. Jiang W, Beatty BG. Assignment of Mep 1a to mouse chromosome band 17C1-D1 by in situ hybridization. Cytogenet Cell Genet 76: 206-207, 1997.
26. Jiang W, Dewald G, Brundage E, Mucher G, Schildhaus HU, Zerres K, Bond JS. Fine mapping of MEP1A, the gene encoding the alpha subunit of the metalloendopeptidase meprin, to human chromosome 6P21. Biochem Biophys Res Commun 216: 630-635, 1995.
27. Koltun M, Nikolovski J, Strong K, Nikolic-Paterson D, Comper WD. Mechanism of hypoalbuminemia in rodents. Am J Physiol Heart Circ Physiol 288: H1604-H1610, 2005.
28. Kruse MN, Becker C, Lottaz D, Kohler D, Yiallouros I, Krell HW, Sterchi EE, Stocker W. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem J 378: 383-389, 2004.
29. Lottaz D, Buri C, Monteleone G, Rosmann S, Macdonald TT, Sanderson IR, Sterchi EE. Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease. Biol Chem 388: 337-341, 2007.
30. Lottaz D, Maurer CA, Hahn D, Buchler MW, Sterchi EE. Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma. Cancer Res 59: 1127-1133, 1999.
31. Norman LP, Jiang W, Han X, Saunders TL, Bond JS. Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles. Mol Cell Biol 23: 1221-1230, 2003.
32. Norman LP, Matters GL, Crisman JM, Bond JS. Expression of meprins in health and disease. Curr Top Dev Biol 54: 145-166, 2003.
33. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88: 1379-1406, 2008.
34. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr, Foley E, Moskaluk CA, Bickston SJ, Cominelli F. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 162: 6829-6835, 1999.
35. Sivakumar PV, Westrich GM, Kanaly S, Garka K, Born TL, Derry JM, Viney JL. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50: 812-820, 2002.
36. Sterchi EE, Stocker W, Bond JS. Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Aspects Med 29: 309-328, 2008.
37. Sun Q, Jin HJ, Bond JS. Disruption of the meprin alpha and beta genes in mice alters homeostasis of monocytes and natural killer cells. Exp Hematol 37: 346-356, 2009.
38. Yura RE, Bradley SG, Ramesh G, Reeves WB, Bond JS. Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge. Am J Physiol Renal Physiol 296: F135-F144, 2009.